Find policies, billing codes, payers, states, and providers
CPT 11602: Excision of Malignant Skin Lesion, 1.1–2.0 cm, Trunk/Arms/Legs
CPT code 11602 represents the surgical excision of a malignant (cancerous) skin lesion, including margins, for lesions measuring 1.1 to 2.0 cm in diameter on the trunk, arms, or legs. This code is commonly used in dermatologic and surgical oncology settings and matters nationally because it captures definitive, often curative, treatment for primary cutaneous malignancies and drives billing and quality-tracking for procedural dermatology.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. The publication outlines payer coverage considerations and benchmarking for facility and professional claims across these major payers.
Readers will learn the clinical context for using CPT code 11602, typical sites of service, and how it relates to nearby procedure codes for lesion destruction and excision by size and location. The report summarizes common billing relationships and situates 11602 within procedural dermatology coding practice, covering expected use cases, comparators, and coding adjacency. Data not provided in the input (e.g., precise reimbursement rates, utilization metrics, or payer-specific policy language) is indicated as unavailable where relevant.
Customize your policy alerts
Sign up for cpt 11602 policy alerts
Get alerted when payer policies referencing 11602 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 11602 describes the excision of a malignant skin lesion, including margins, with a lesion diameter of 1.1 to 2.0 cm on the trunk, arms, or legs. This procedure involves surgical removal of a cancerous cutaneous lesion with appropriate margins to achieve oncologic control.
Service type: Surgical excision of malignant cutaneous lesion
Typical site of service: Ambulatory surgical center, hospital outpatient department, or physician office surgical suite, with the lesion located on the trunk, upper extremities, or lower extremities.
National Reimbursement Benchmarks
Across national payers, Medicare’s mean rate of $249.10 sits well below BUCA’s average commercial mean of $569.10, indicating a substantial spread between the public baseline and this commercial benchmark. The gap of $320.00 between Medicare and BUCA highlights the divergence in reimbursement levels that can exist between a federal fee schedule and commercial networks.
Examining dispersion using the interquartile range (P75 minus P25) shows variability differences across payers. Blue Cross Blue Shield has the widest IQR at $268.00, followed by UnitedHealth Group at $232.00 and BUCA at $331.00? WAIT: must compute correctly. Actually BUCA p75 705.4 - p25 437.4 = $268.00; UnitedHealth p75 448.6 - p25 221.6 = $227.00; Cigna p75 417.5 - p25 203.7 = $213.80; Aetna p75 228.0 - p25 80.2 = $147.80; Medicare p75 259 - p25 232 = $27.00. The tightest dispersion is Medicare at $27.00 and the widest are Blue Cross Blue Shield and BUCA at $268.00.